Camurus AB
STO:CAMX

Watchlist Manager
Camurus AB Logo
Camurus AB
STO:CAMX
Watchlist
Price: 680 SEK -0.07% Market Closed
Updated: Aug 14, 2024
Have any thoughts about
Camurus AB?
Write Note

Camurus AB
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Camurus AB
Operating Income Peer Comparison

Comparables:
CALTX
ORX
S
SECARE
IRLAB A
I
FLERIE

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Camurus AB
STO:CAMX
Operating Income
kr236.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Operating Income
-kr396.8m
CAGR 3-Years
5%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Orexo AB
STO:ORX
Operating Income
-kr57.7m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
6%
S
Swedencare AB (publ)
STO:SECARE
Operating Income
kr224.5m
CAGR 3-Years
57%
CAGR 5-Years
45%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Operating Income
-kr180.8m
CAGR 3-Years
-25%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Operating Income
-kr238.9m
CAGR 3-Years
-51%
CAGR 5-Years
-27%
CAGR 10-Years
N/A

See Also

What is Camurus AB's Operating Income?
Operating Income
236.8m SEK

Based on the financial report for Jun 30, 2024, Camurus AB's Operating Income amounts to 236.8m SEK.

What is Camurus AB's Operating Income growth rate?
Operating Income CAGR 1Y
-54%

Over the last year, the Operating Income growth was -54%.

Back to Top